Proteomic biomarkers for lung cancer progression.
CONCLUSION: A comparative analysis was also carried out on related transcriptomic datasets, which indicates that the proposed biomarkers provide discerning power for accurate stage prediction, and will be improved when larger-scale proteomic quantitative technologies become available.
PMID: 29424557 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Internal Medicine | Lung Cancer | Skin Cancer | Squamous Cell Carcinoma | Study